Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,417 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

NCT02125318

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +21 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Escondido, California, United States
  • California Cancer Associates For Research and Excellence Fresno, California, United States
View Trial Details
Completed

Alisertib for Acute Myeloid Leukemia

NCT01779843

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00475150

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +17 more
Locations
  • Howard University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

NCT00481247

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Molecular Md Portland, Oregon, United States
  • Local Institution Buenos Aires, Argentina
  • Local Institution Capital Federal, Buenos Aires, Argentina
  • Local Institution Capital Federal, Buenos Aires, Argentina
View all 109 locations
View Trial Details

Related conditions